Micron, Inc. has entered into a business alliance agreement with Proswell Medical Company. To mark this alliance, one of our employees will be speaking at their web seminar called “Proswell University.” (Note: This seminar will be in Chinese.)
Topic: Anti-Tumor Clinical Trial Design: Error Sources and Countermeasures for the Imaging Endpoint Process
（中国語題：抗肿瘤药的临床试验设计：影像终点程序中的误差因素和对应方法）
Speaker: Dr. Mari Anzai Micron, Inc. Imaging Service Department
Time: Aug 24, 2020 16:00 Japan time (15:00 in Beijing time）
Description:
In the field of developing anti-tumor drugs, imaging endpoints, such as the objective response rate (ORR), progression-free survival (PFS), etc., are assessed using medical images, namely CT, MRI, and PET, have become widely used in clinical trials. Acquiring the imaging endpoints includes scanning to obtain images, assessing the image data, and so on. During scanning, imaging manufacturer discrepancies, scanning parameter settings, and other factors may result in imaging endpoint errors. On the other hand, during the assessment, the reader’s subjective judgment or assessment bias may also result in endpoint errors. The standardization of scanning and assessment is necessary to avoid errors and acquire accurate study results. This lecture will focus on the source of errors in the results and the corresponding resolutions.
How to register:
Please refer to Proswell Medical Company’s website
https://www.proswell.com.cn/post.html?id=5f1242271cca8a46d26e2480
Category
Please feel free to contact us
We provide comprehensive, end‑to‑end clinical development support, with imaging at its core.
With more than 20 years of experience, our team of imaging specialists in Japan and around the world tackles the complex challenges of imaging evaluation in pharmaceutical and medical device development. We deliver optimal, project‑specific solutions for each client.